No 1 Date of announcement 2026/03/12 Time of announcement 23:33:33 Addresser Shu-Ling Cheng Addresser’s Position President Addresser’s Phone Number 02-26558860 Subject EU NB issued the EU market approval for Bonvadis that grants marketing authorization across all 27 EU member states for acute and chronic wounds, and scar management. To which item it meets Subparagraph...Read More
No 5 Date of announcement 2026/03/05 Time of announcement 17:17:16 Subject Oneness Board of Directors resolved to convene the Annual Shareholders’ Meeting of 2026. (additional matters) To which item it meets paragraph 17 Date of events 2026/03/05 Statement Date of the board of directors’ resolution：2026/03/05 Shareholders meeting date：2026/05/20 Shareholders meeting location：8F., No. 11, Zhongshan...Read More
No 4 Date of announcement 2026/03/05 Time of announcement 16:58:36 Subject The board of directors of Oneness approved a resolution on issuance of the Restricted Stock Awards (RSA) of 2026. To which item it meets paragraph 11 Date of events 2026/03/05 Statement Resolution date of the board of directors:2026/03/05 Expected issue price: Issued for...Read More
No 3 Date of announcement 2026/03/05 Time of announcement 16:58:36 Subject The board of directors of the Company approved a resolution on the 1st issue of the employee stock option certificate of 2026. To which item it meets paragraph 11 Date of events 2026/03/05 Statement Date of the board of directors resolution:2026/03/05 Issue period:...Read More
No 2 Date of announcement 2026/03/05 Time of announcement 16:52:49 Subject The Board of Directors resolved not to distribute dividends. To which item it meets paragraph 14 Date of events 2026/03/05 Statement Date of the board of directors resolution:2026/03/05 Year or quarter which dividends belong to :2025 Period which dividends belong to:2025/01/01~2025/12/31 Appropriations of...Read More
No 1 Date of announcement 2026/03/05 Time of announcement 16:35:11 Subject The Company’s 2025 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2026/03/05 Statement Date of the board of directors submitted or approved: 2026/03/05 Date of the audit committee approved: 2026/03/05...Read More
No 1 Date of announcement 2026/02/24 Time of announcement 18:54:38 Subject A Phase 1 clinical trial of SNS851 has been approved by Australia HREC and acknowledged by Australia TGA. To which item it meets paragraph 10 Date of events 2026/02/24 Statement Date of occurrence of the event: 2026/02/24 New drug name or code: SNS851...Read More
S&P Global, the world’s leading authority of ESG ratings and research, recently released “The S&P Global Sustainability Yearbook 2026.” Microbio Group delivered an outstanding performance: its subsidiary Oneness Biotech Co., Ltd. (4743) has been selected for the fourth consecutive year, while Diamond BioFund Inc. (6901) and Microbio Co., Ltd. (4128) made their debut on...Read More
No 1 Date of announcement 2026/02/22 Time of announcement 10:27:58 Addresser Shu-Ling Cheng Addresser’s Position President Addresser’s Phone Number 02-26558860 Subject Bonvadis topical cream received medical device marketing authorization approval for all indications in wounds by INVIMA Colombia. To which item it meets Subparagraph 10 Date of events 2026/02/22 Statement Date of occurrence of...Read More
No 1 Date of announcement 2026/02/07 Time of announcement 11:34:57 Addresser Shu-Ling Cheng Addresser’s Position President Addresser’s Phone Number 02-26558860 Subject Oneness ON101 cream promotes healing of an essential thrombocythemia–associated toe ulcer, with findings published in the SCI journal, Journal of Wound Care To which item it meets Subparagraph 53 Date of events 2026/02/07...Read More
